Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents-Reference-Cited by-同舟云学术

Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents

Published:2015-05-01 Issue:5 Volume:10 Page:e0119549
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pasdar Elham Alizadeh,Smits Michael,Stapelberg Michael,Bajzikova Martina,Stantic Marina,Goodwin Jacob,Yan Bing,Stursa Jan,Kovarova Jaromira,Sachaphibulkij Karishma,Bezawork-Geleta Ayenachew,Sobol Margaryta,Filimonenko Anatoly,Tomasetti Marco,Zobalova Renata,Hozak Pavel,Dong Lan-Feng,Neuzil Jiri

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference65 articles.

1. Malignant mesothelioma: biology, diagnosis and therapeutic approaches;M Tomasetti;Curr Mol Pharm,2009

2. Advances in the biology of malignant pleural mesothelioma;P Zucali;Cancer Treat Rev,2011

3. Elsevier;P Baas,2002

4. The global reorganization and revitalization of the asbestos industry, 1970–2007;J Rice;Int J Health Serv,2011

5. Influence of tumour micro-environment heterogeneity on therapeutic response;MR Junttila;Nature,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diving into cancer OXPHOS – The application of metabolic control analysis to cell and tissue research;Biosystems;2023-11

2. The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints;International Journal of Molecular Sciences;2023-02-09

3. The application of cancer stem cell model in malignant mesothelioma;Critical Reviews in Oncology/Hematology;2022-06

4. Splicing deregulation, microRNA and notch aberrations: fighting the three-headed dog to overcome drug resistance in malignant mesothelioma;Expert Review of Clinical Pharmacology;2022-03-04

5. Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells;Cancer Drug Resistance;2022